CB Therapeutics News Room

Follow us. We’re making news!

December 4, 2019

CB Therapeutics Achieves Major Breakthrough in the Biosynthesis of Psilocybin, Psilocin and Related Tryptamine-based Compounds

SAN DIEGO–(BUSINESS WIRE)
CB Therapeutics, Inc. has achieved the successful biosynthesis of psilocybin, psilocin and related tryptamine-based compounds typically found in plants and fungi and has filed a patent for the production process… Read More

November 14, 2019

CB Therapeutics Continues to Advance its Intellectual Property Portfolio with New Patent Awards

SAN DIEGO–(BUSINESS WIRE)
CB Therapeutics has been awarded a patent on Oct 10, 2019, titled “Isolated codon optimized Nucleic Acids”. This patent covers inventions related to the optimization of the entire biosynthetic cannabinoid pathway… Read More

Sept 25, 2019

CB Therapeutics Advances Its Intellectual Property Portfolio for Its Cellular Agriculture Platform with New Patent Applications

SAN DIEGO–(BUSINESS WIRE)
CB Therapeutics has developed a patent-pending platform for creating and annotating… Read More

July 11, 2019

CB Therapeutics Achieves Key Production Milestone

SAN DIEGO–(BUSINESS WIRE)
CB Therapeutics is an innovative biotechnology company focused on the production of high value molecules, compounds and rare ingredients from simple sugars… Read More

March 20, 2019

CB Therapeutics Secures new Research and Production Facility

SAN DIEGO–(BUSINESS WIRE)
CB Therapeutics is an innovative biotechnology company focusing on research and production of cannabinoids. The company utilizes… Read More

August 22, 2018

The top 10 startups from Y Combinator’s Demo Day S18 Day 2

Sher Butt, a former lab directory at Steep Hill, saw that cannabinoids were as close to a miracle cure for pain, epilepsy and other chronic conditions as medicine was going to get… Read More

We have advanced the science of Cellular Agriculture to build on its promise to meet the health and wellness needs of mankind.